EP2227296
COMBINATION OF ANTI-CTLA4 ANTIBODY WITH TUBULIN MODULATING AGENTS FOR THE TREATMENT OF PROLIFERATIVE DISEASES
:
EP einkaleyfi: Þýðing ekki lögð inn:
7.1.2009:
25.11.2015:
09701364.3
:
6.1.2029
:
COMBINATION OF ANTI-CTLA4 ANTIBODY WITH TUBULIN MODULATING AGENTS FOR THE TREATMENT OF PROLIFERATIVE DISEASES
7.1.2009
25.11.2015
:
Bristol-Myers Squibb Company:
Route 206 and Province Line Road, 08543, Princeton, NJ, US
:
JURE-KUNKEL, Maria:
Princeton, NJ, US
:
19778 P:
8.1.2008:
US
:
56957 P:
29.5.2008:
US
:
WO2009089260:
7.1.2009
:
A61P 35/00, A61K 31/385, A61K 45/06, A61K 39/395